Citations

Clear

448 citation(s) found for "Brinjikji, W".

Clot permeability and histopathology: is a clot’s perviousness on CT imaging correlated with its histologic composition?
Kadirvel, Ramanathan , Johnson, C. Daniel, Doyle, Karen, Kallmes, David F. , Brinjikji, Waleed , Benson, John Charles, Fitzgerald, Sean T, Johnson, Collin, Dai, Daying , Benson, John C. , Fitzgerald, Seán

Mayo Clinic

Journal of NeuroInterventional Surgery | June 25, 2019 | Volume: 12 | Issue: 1 | Pages: 38-42

10.1136/neurintsurg-2019-014979 | PMID 31239329 Get It

Background Clot perviousness in large vessel occlusion has been shown to be associated with improved recanalization outcomes with mechanical thrombectomy and intravenous thrombolysis. Objective To evaluate the association between clot perviousness based on thrombus attenuation increase (TAI) on CT, and histologic composition of clots in acute ischemic stroke (AIS). Methods A retrospective review was completed of patients with AIS secondary to large vessel occlusion, non-contrast CT (NCCT) and CT angiography (CTA) images, and histologic analysis of the retrieved clot. TAI was measured by subtracting clot attenuation on NCCT from the attenuation on CTA. Up to 3 regions of interest (ROIs) were evaluated on each clot; the average attenuation was used for analysis if multiple ROIs were assessed. Pervious clots were defined as TAI ≥10 Hounsfield units (HUs); impervious clots had TAI <10 HU. Histopathologic analyses of clots were assessed for relative compositions of red blood cells (RBCs), white blood cells (WBCs), fibrin, and platelets/other. Results 57 patients were included. Pervious clots were more likely to be RBC rich (p=0.04); impervious clots were more likely to be fibrin and WBC rich (p=0.01 for both). Pervious clots also had greater RBC density than impervious clots (49.8% and 33.0%, respectively; p=0.006); fibrin density of pervious clots was lower than that of impervious clots (17.8% and 23.2%, respectively; p=0.02). Conclusion Clot perviousness, assessed on NCCT and CTA imaging, is associated with higher RBC density and lower fibrin density, offering a possible explanation for the higher rates of successful thrombectomy and favorable clinical outcome seen in such patients.
Letter by Kallmes et al Regarding Article, “Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0–5”
Kallmes, David F. , Brinjikji, Waleed , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | June 14, 2019 | Volume: 50 | Issue: 7 | Pages: No page available

10.1161/strokeaha.119.025741 | PMID 31195939 Get It

Carotid Cavernous Fistula Mimicking Hemicrania Continua: A Case Report
Fiebelkorn, Catherine Arnold, Chen, John J. , Brinjikji, Waleed , Eckel, Laurence J. , Arnold Fiebelkorn, Catherine, Boes, Christopher J. , Chen, John J , Lanzino, Giuseppe

Mayo Clinic

Headache: The Journal of Head and Face Pain | June 5, 2019 | Volume: 59 | Issue: 8 | Pages: 1365-1369

10.1111/head.13566 | PMID 31166017 Get It

Background Hemicrania continua is a primary headache disorder characterized by a continuous, unilateral headache associated with ipsilateral cranial autonomic features that responds to indomethacin. By definition, the symptoms are not referable to an underlying structural pathology. However, several cases of secondary hemicrania continua related to underlying structural lesions have been reported. Case We present a case of a 53‐year‐old male with a prolonged, right‐sided headache associated with intermittent right‐sided ptosis, conjunctival injection, tearing, and nasal congestion, suggestive of hemicrania continua, who was found to have an indirect carotid‐cavernous fistula, and who, after endovascular treatment of the fistula, had resolution of his symptoms. Conclusion Alternative, and perhaps less common, causes of headache should be considered when the clinical presentation is atypical or does not clearly fulfill diagnostic criteria for primary headache disorders. Carotid cavernous fistulas should be included within this differential, and represent a potentially treatable and reversible cause of otherwise refractory headache.
Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source
Wang, Shunli , Douglas, Andrew , Kadirvel, Ramanathan , Thacker, Ike, Gounis, Matthew J. , Chueh, Ju-Yu , Puri, Ajit S , Sauvageau, Eric , Aghaebrahim, Amin, Kvamme, Peter , Kallmes, David F. , Doyle, Karen , Brinjikji, Waleed , Fitzgerald, Seán , Dai, Daying , Layton, Kennith F. , Almekhlafi, Mohammed , Demchuk, Andrew M. , Hanel, Ricardó A. , Yoo, Albert J. , Mendes Pereira, Vitor , Kayan, Yasha , Almandoz, Josser E Delgado , Nogueira, Raul G. , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | May 29, 2019 | Volume: 50 | Issue: 7 | Pages: 1907-1910

10.1161/strokeaha.118.024543 | PMID 31138084 Get It

Background and Purpose— Nearly 30% of large vessel occlusion acute ischemic stroke clots are from an unknown source. We assessed histological clot composition in a series of patients with large vessel occlusion and investigated correlations between clot composition and stroke pathogenesis. Methods— As part of the multi-institutional STRIP registry (Stroke Thromboembolism Registry of Imaging and Pathology), consecutive emboli retrieved during mechanical thrombectomy were stained using Martius Scarlett Blue and analyzed using machine learning software. We assessed proportions of red blood cells, fibrin, platelets, and white blood cells. Correlations between clot components and stroke pathogenesis (large artery atherosclerosis, cardioembolism, and stroke of undetermined pathogenesis) were assessed using SPSS22. Results— One hundred five patients were included. The proportion of platelet-rich clots (55.0% versus 21.2%; P =0.005) and percentage of platelet content (22.1±4.2% versus 13.9±14.2%; P =0.03) was significantly higher in the large artery atherosclerosis group compared with the cardioembolic group. The proportion of platelet-rich clots (50.0% versus 21.2%; P =0.024) was also significantly higher in the cryptogenic group compared with cardioembolic cases. Large artery atherosclerosis and cryptogenic cases had a similar proportion of platelet-rich clots (55.0% versus 50.0%; P =0.636). There was no significant difference between stroke pathogenesis and the other major clot components. Conclusions— High platelet content of emboli is associated with a large artery atherosclerosis etiology of large vessel occlusion.
Mystery Case: Missed diagnosis of hereditary hemorrhagic telangiectasia presenting with recurrent ischemia
Brinjikji, Waleed , Wood, Christopher P. , Iyer, Vivek

Mayo Clinic

Neurology | May 28, 2019 | Volume: 92 | Issue: 22 | Pages: 1068-1069

10.1212/wnl.0000000000007568 | PMID 31133563 Get It

Nuances of transarterial and transvenous embolization of a large tentorial arteriovenous fistula
Rinaldo, Lorenzo , Brinjikji, Waleed , Rangel-Castilla, Leonardo , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | April 9, 2019 | Volume: 46 | Issue: Suppl_2 | Pages: V12

10.3171/2019.2.focusvid.18674 | PMID 30939437 Get It

An 80-year-old female presented with a long history of severe pulsatile tinnitus, vertigo, and decreased hearing. She was found to have a large right-sided tentorial arteriovenous fistula (AVF) with enlarged deep draining veins, including the vein of Rosenthal. The patient underwent Onyx embolization of the fistula via a combined transarterial and transvenous approach resulting in complete obliteration of the fistula. Her symptoms improved immediately after the procedure and at 6-months’ follow-up she was clinically asymptomatic with no evidence of residual fistula on neuroimaging. Transvenous embolization of AVF is at times necessary when transarterial access is not possible. The video can be found here: https://youtu.be/uOMHY7eaOoQ .
Remote ischemic preconditioning for elective endovascular intracranial aneurysm repair: a feasibility study
Seyedsaadat, Seyed Mohammad , Castilla, Leonardo Rangel, Cloft, Harry J. , Blezek, Daniel J. , Theiler, A. , Kadirvel, Ramanathan , Brinjikji, Waleed , Kallmes, David F. , Mohammad Seyedsaadat, Seyed , Rangel Castilla, Leonardo, Theiler, Amy, Lanzino, Giuseppe

Mayo Clinic

The Neuroradiology Journal | April 3, 2019 | Volume: 32 | Issue: 3 | Pages: 166-172

10.1177/1971400919842059 | PMID 30942660 Get It

Objectives Remote ischemic preconditioning has been proposed as a possible potential treatment for ischemic stroke. However, neuroprotective benefits of the pre-procedural administration of remote ischemic preconditioning have not been investigated in patients undergoing an elective endovascular intracranial aneurysm repair procedure. This study investigated the safety and feasibility of remote ischemic preconditioning in patients with an unruptured intracranial aneurysm who undergo elective endovascular treatment. Methods In this single-center prospective study, patients with an unruptured intracranial aneurysm undergoing elective endovascular treatment with flow diverters or coiling were recruited. Patients received three intermittent cycles of 5 minutes arm ischemia followed by reperfusion using manual blood cuff inflation/deflation less than 5 hours prior to endovascular treatment. Patients were monitored and followed up for remote ischemic preconditioning-related adverse events and ischemic brain lesions by diffusion -weighted magnetic resonance imaging within 48 hours following endovascular treatment. Results A total of seven patients aged 60 ± 5 years with an unruptured intracranial aneurysm successfully completed a total of 21 sessions of remote ischemic preconditioning and the required procedures. Except for two patients who developed skin petechiae over their arms, no other serious procedure-related adverse events were observed as a result of the remote ischemic preconditioning procedure. On follow-up diffusion -weighted magnetic resonance imaging, a total of 19 ischemic brain lesions with a median (interquartile range) volume of 245 (61–466) mm 3 were found in four out of seven patients. Conclusions The application of remote ischemic preconditioning prior to endovascular intracranial aneurysm repair was well tolerated, safe and clinically feasible. Larger sham-controlled clinical trials are required to determine the safety and efficacy of this therapeutic strategy in mitigating ischemic damage following endovascular treatment of intracranial aneurysms.
Clots retrieved by mechanical thrombectomy from acute ischemic stroke patients show no evidence of bacteria
Khashim, Zenith , Fitzgerald, Seán , Kadirvel, Ramanathan , Doyle, Karen , Brinjikji, Waleed , Kallmes, David F. , Dai, Daying , Brinjikji, Waleed , Fitzgerald, Seán

Mayo Clinic

Interventional Neuroradiology | April 3, 2019 | Volume: 25 | Issue: 5 | Pages: 502-507

10.1177/1591019918819707 | PMID 30939960 Get It

Background Bacteria and bacterial components have been associated with the activation of coagulation factors and initiating the blood clot formation. The aim of this study was to investigate whether bacterial populations are present in clots retrieved from patients that have suffered a large vessel occlusion acute ischemic stroke (AIS). Materials and methods Clot samples were collected from 20 AIS patients who underwent clot retrieval with mechanical thrombectomy. Patient clinical demographic details were noted. Expression of bacterial 16S rDNA was analyzed by standard and real-time polymerase chain reaction (PCR). Gram staining was performed to identify Gram-positive and Gram-negative bacteria. Results Both the real-time and standard PCR demonstrated no expression of 16S rDNA in any of the 20 clots samples from AIS patients. Gram staining results showed no expression of Gram-positive or Gram-negative bacteria present in the clot samples. Conclusion Our current study found no bacteria populations in the clots of AIS patients.
Response to letter by Samuels et al.
Brinjikji, Waleed , Albers, Gregory W. , Koch, Sebastian , Rabinstein, Alejandro A.

Mayo Clinic

International Journal of Stroke | April 1, 2019 | Volume: 14 | Issue: 4 | Pages: NP3-NP3

10.1177/1747493019840929 | PMID 30935348 Get It

Pipeline Endovascular Device vs Stent-Assisted Coiling in Small Unruptured Aneurysms: A Cost-Effectiveness Analysis
Malhotra, Ajay , Brinjikji, Waleed , Miller, Timothy , Malhotra, Ajay , Wu, Xiao Juan , Matouk, Charles , Sanelli, Pina C. , Gandhi, Dheeraj

Mayo Clinic

Neurosurgery | March 27, 2019 | Volume: 85 | Issue: 6 | Pages: E1010-E1019

10.1093/neuros/nyz130 | PMID 31329957 Get It

Abstract BACKGROUND Both stent-assisted coiling (SAC) and flow diversion with the Pipeline Embolization device (PED; Medtronic Inc) have been shown to be safe and clinically effective for treatment of small (<10 mm) unruptured aneurysms. However, the economic impact of these different techniques has not been established. OBJECTIVE To analyze the cost-effectiveness between stent-assisted coiling and flow diversion using PED, including procedural costs, long-term outcomes, and aneurysm recurrence. METHODS A decision-analytical study was performed with Markov modeling methods to simulate patients undergoing SAC or PED for treatment for unruptured aneurysms of sizes 5 and 7 mm. Input probabilities were derived from prior literature, and 1-way, 2-way, and probabilistic sensitivity analyses (PSA) were performed. RESULTS In base case calculation and PSA, PED was the dominant strategy for both the size groups, with and without consideration of indirect costs. One-way sensitivity analyses show that the conclusion remained robust when varying the retreatment rate of SAC from 0% to 50%, and only changes when the retreatment rate of PED > 49%. PED remained the more cost-effective strategy when the morbidity and mortality of PED increased by <55% and when those of SAC decreased by <37%. SAC only became cost-effective when the total cost of PED is >$73000 more expensive than the total cost of SAC. CONCLUSION With increasing use of PED for treatment of small unruptured anterior circulation aneurysms, our study indicates that PED is cost-effective relative to stent coiling irrespective of aneurysm size. This is due to lower aneurysm recurrence rate, as well as better health outcomes.